Clinical Trials

Accrual Status
Limit to SWOG Trials

1033 Results

View
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7984

The Treatment of Chronic Stage CML with Pulse, Intermittent Busulfan Therapy with or without Oral Vitamin A
Activated
07-10-1980
Closed
04-01-1987
Closed
Phase
SWOG Clinical Trial Number
SWOG-8014

Colchicine in Refractory Chronic Lymphocytic Leukemia
Activated
07-07-1980
Closed
10-23-1981
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8017

5-FU, Adriamycin, Streptozotocin and Cyclophosphamide (FAC-S) in the Treatment of Metastatic Carcinoid Tumors
Activated
07-07-1980
Closed
01-19-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8004

Evaluation of DHAD in Soft Tissue and Bone Sarcomas
Activated
07-03-1980
Closed
07-28-1981
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8009

Evaluation of Diydroxythracenedione (DHAD) in Patients with Refractory Small Cell Lung Cancer
Activated
07-03-1980
Closed
05-11-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8065

DHAD in Adults with Metastatic Malignant Melanoma
Activated
07-02-1980
Closed
10-18-1983
Closed
Phase
SWOG Clinical Trial Number
SWOG-8008

Evaluation of Dihydroxyanthracenedione (DHAD) in Refractory Breast Cancer
Activated
07-02-1980
Closed
09-10-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-8010

Evaluation of Dihydroxyanthracenedione (DHAD) in Advanced Prostate Cancer
Activated
07-02-1980
Closed
12-28-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-8005

Evaluation of Dihydroxyanthracenedione (DHAD) in Refractory Malignant Lymphomas
Research Committee(s)
Lymphoma
Activated
07-02-1980
Closed
05-10-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-8011

Evaluation of Dihydroxyanthracenedione (DHAD) in Patients with Advanced Renal Cell Carcinoma
Activated
07-02-1980
Closed
04-14-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-8063

Evaluation of Anguidine (NSC-141537) in Refractory Adult Acute Nonlymphocytic Leukemia
Activated
04-22-1980
Closed
04-14-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-7985

Combined Modality Treatment for ER - Breast Cancer
Activated
03-03-1980
Closed
09-10-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-7940/41

Evaluation of MGBG in Metastatic Adenocarcinoma of the Large Bowel
Activated
02-27-1980
Closed
09-23-1980
Closed
Phase
SWOG Clinical Trial Number
SWOG-7940/43

Evaluation of Gallium Nitrate in Metastatic Adenocarcinoma of the Large Bowel
Activated
02-27-1980
Closed
09-23-1980
Closed
Phase
SWOG Clinical Trial Number
SWOG-7940

Evaluation of 5-FU vs. A Phase II Drug in Metastatic Adeno- carcinoma of the Large Bowel
Activated
02-27-1980
Closed
05-05-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-8062

Evaluation of Vindesine in Head and Neck Cancer
Activated
02-25-1980
Closed
10-23-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-8061

Evaluation of Vindesine in Gastrointestinal Cancer
Activated
02-22-1980
Closed
09-28-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-7902

Combined Modality Therapy with Chemotherapy, Radio- therapy and Surgery vs. Radiotherapy & Surgery in AdvancedPreviously Untreated (Unrestable) Stage III & IV Epidermoid Cancer of the Head and Neck
Activated
02-18-1980
Closed
06-02-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7956

Study of Postinfarction Nephrectomy and Medroxy- progesterone Acetate (Depo-Provera) in Metastatic Renal Cell Carcinoma
Activated
02-09-1980
Closed
01-19-1984
Closed
Phase
SWOG Clinical Trial Number
SWOG-7980

Study of Cis-Diammine Dichlorophlatinum-II (DDP) for Recurrent Gliomas
Activated
02-05-1980
Closed
05-11-1982